Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Re: Photonics-led Consortium Leverages $3B in Private Cancer Research

There is so much potential for POET to disrupt in many verticals. From hi-tech nuts and bolts type products to eventually processors. Maybe the TRAB helped POET define standards that can eventually be released to industry for all to follow? Let hope that POET with its disruptive potential that it translates into many such opportunites (Some of the buzz-acronymns here: VCSEL, AOC, Hfet, and so on). Some of these products are years off while others are hopefully almost imminent? I think the next time this company returns to a 200+ million market cap vying for higher ground, we will generally get a confirmation that the inroads of poet will be successful.

Monolithic

Share
New Message
Please login to post a reply